In this Cancer Research Institute video, meet Ariella Chivil, a Hodgkin lymphoma patient. She was diagnosed while in college, and, back then, completed treatment considered standard for the disease in the hopes it would be enough to put it behind her.
Unfortunately, the lymphoma returned.
Fourteen cancer treatments later, Ariella participated in an immunotherapy clinical trial for the drug nivolumab (Opdivo).
Watch her story with the video above.
Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.